Open main menu

Transfersome is a trademark registered by the German company IDEA AG, which refers to its proprietary drug delivery technology, an artificial vesicle designed to exhibit the characteristics of a cell vesicle suitable for controlled and potentially targeted drug delivery. Some evidence has shown efficacy for its use for drug delivery without causing skin irritation,[1] potentially being used to treat skin cancer.[2]

ReferencesEdit

  1. ^ Gupta, Ankit; Aggarwal, Geeta; Singla, Samita; Arora, Ritika (August 31, 2012). "Transfersomes: A Novel Vesicular Carrier for Enhanced Transdermal Delivery of Sertraline: Development, Characterization, and Performance Evaluation". Sci Pharm. 80 (4): 1061–1080. doi:10.3797/scipharm.1208-02. PMC 3528046. PMID 23264950.
  2. ^ Rai, Shubhra; Pandey, Vikas; Rai, Gopal (June 7, 2017). "Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art". Nano Rev Exp. 8 (1): 1325708. doi:10.1080/20022727.2017.1325708. PMC 6167026. PMID 30410704.